Cleerly Review — Coronary CT Analysis
Cleerly quantifies coronary artery disease from CT scans to improve cardiac risk assessment.
Cleerly excels in automating coronary artery disease quantification with clinical-grade precision.
- FDA-cleared for clinical use
- Detailed quantitative plaque and stenosis analysis
- Improves cardiac risk assessment accuracy
- Limited to coronary CT angiography use cases
- No public API or pricing information available
Is Cleerly Right for You?
A quick checklist to help you decide.
Ideal for: Cardiologists, radiologists, and healthcare providers specializing in cardiac imaging and coronary artery disease management.
Less suited for: General radiologists, non-cardiac specialists, or teams outside healthcare who need construction or property AI solutions.
Bottom line: Clinical accuracy and FDA clearance for coronary artery disease quantification from CT scans.
Pros
Cons
Free
Basic access for individual users
- Limited scan analyses
- Basic reporting
Offers a freemium pricing model with limited public details; contact sales for full pricing and enterprise options.
What is this tool?
How much does it cost?
Does it have a free plan?
What integrations does it support?
Who is it best for?
No reviews yet. Be the first to review Cleerly!
Scores are calculated algorithmically from feature coverage, pricing, user feedback & benchmark data — not influenced by commercial relationships. How we score → · Vendor Data Policy